Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade

BACKGROUND: Although the second-generation androgen receptor inhibitors and taxanes have recently been recommended for the initial treatment of metastatic prostate cancer, bicalutamide and flutamide are still used in a large number of cases. Therefore, it is important to elucidate the clinical chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Obinata, Daisuke, Hashimoto, Sho, Uchida, Hideaki, Nakahara, Ken, Yoshizawa, Tsuyoshi, Mochida, Junichi, Yamaguchi, Kenya, Takahashi, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148407/
https://www.ncbi.nlm.nih.gov/pubmed/37118708
http://dx.doi.org/10.1186/s12894-023-01233-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148407/
https://www.ncbi.nlm.nih.gov/pubmed/37118708
http://dx.doi.org/10.1186/s12894-023-01233-6

Ejemplares similares